US Stock MarketDetailed Quotes
ZBIO Zenas BioPharma
- 12.000
- +1.560+14.94%
Close Nov 22 16:00 ET
- 12.000
- 0.0000.00%
Post 20:02 ET
501.49MMarket Cap-3887P/E (TTM)
12.365High9.450Low785.07KVolume10.050Open10.440Pre Close8.89MTurnover6.68%Turnover RatioLossP/E (Static)41.79MShares26.25152wk High1.40P/B141.12MFloat Cap9.45052wk Low--Dividend TTM11.76MShs Float26.251Historical High--Div YieldTTM27.92%Amplitude9.450Historical Low11.321Avg Price1Lot Size
Zenas BioPharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 50M | 0 | 50M | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --50M | --0 | --50M | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 185.09%40.98M | 110.01%39.7M | 44.49%27.58M | 2.59%77.15M | 30.49%24.78M | 14.38M | 18.91M | 19.09M | 75.2M | 18.99M |
| Selling and administrative expenses | 48.37%7.45M | 47.74%5.9M | 31.93%4.93M | 26.68%17.11M | 35.27%4.36M | --5.02M | --3.99M | --3.74M | --13.51M | --3.22M |
| -General and administrative expense | 48.37%7.45M | 47.74%5.9M | 31.93%4.93M | 26.68%17.11M | 35.27%4.36M | --5.02M | --3.99M | --3.74M | --13.51M | --3.22M |
| Research and development costs | 258.53%33.53M | 126.66%33.81M | 47.55%22.65M | -2.68%60.03M | 29.51%20.42M | --9.35M | --14.92M | --15.35M | --61.69M | --15.77M |
| Operating profit | -215.05%-40.98M | -110.01%-39.7M | -44.49%-27.58M | 63.90%-27.15M | -30.49%-24.78M | 35.62M | -18.91M | -19.09M | -75.2M | -18.99M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 14,962.50%2.38M | 117.01%1.73M | -1,918.18%-222K | 78.05%-9.68M | 9,960.00%493K | -16K | -10.14M | -11K | -44.08M | -5K |
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.27M | --0 |
| Special income (charges) | --0 | ---- | ---- | -900.00%-10M | --0 | --0 | ---- | ---- | ---1M | --0 |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | 900.00%10M | --0 | --0 | ---- | ---- | --1M | --0 |
| Other non- operating income (expenses) | 14,962.50%2.38M | 1,314.79%1.73M | -1,918.18%-222K | 101.09%324K | 9,960.00%493K | ---16K | ---142K | ---11K | ---29.82M | ---5K |
| Income before tax | -208.42%-38.61M | -30.74%-37.98M | -45.57%-27.8M | 69.13%-36.82M | -27.86%-24.29M | 35.61M | -29.05M | -19.1M | -119.28M | -18.99M |
| Income tax | 301K | 0 | ||||||||
| Net income | -208.42%-38.61M | -30.74%-37.98M | -45.57%-27.8M | 68.88%-37.12M | -29.45%-24.59M | 35.61M | -29.05M | -19.1M | -119.28M | -18.99M |
| Net income continuous Operations | -208.42%-38.61M | -30.74%-37.98M | -45.57%-27.8M | 68.88%-37.12M | -29.45%-24.59M | --35.61M | ---29.05M | ---19.1M | ---119.28M | ---18.99M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -208.42%-38.61M | -30.74%-37.98M | -45.57%-27.8M | 68.88%-37.12M | -29.45%-24.59M | 35.61M | -29.05M | -19.1M | -119.28M | -18.99M |
| Preferred stock dividends | 3.77M | |||||||||
| Other preferred stock dividends | 0 | 28.12M | ||||||||
| Net income attributable to common stockholders | -1,136.96%-38.61M | -30.74%-37.98M | -45.57%-27.8M | 68.88%-37.12M | -29.45%-24.59M | 3.72M | -29.05M | -19.1M | -119.28M | -18.99M |
| Basic earnings per share | -2,448.32%-5.02 | 42.78%-0.9544 | 36.29%-0.6986 | 68.90%-2.88 | -29.45%-1.4118 | 0.2138 | -1.6678 | -1.0965 | -9.2613 | -1.0906 |
| Diluted earnings per share | -2,448.32%-5.02 | 42.78%-0.9544 | 36.29%-0.6986 | 68.90%-2.88 | -29.45%-1.4118 | 0.2138 | -1.6678 | -1.0965 | -9.2613 | -1.0906 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
